Related Experiment Video
Updated: Jun 11, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Which cryptic sites are feasible drug targets?
Maria Lazou1, Dima Kozakov2, Diane Joseph-McCarthy3
1Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA.
Cryptic protein sites offer new drug targets, but not all are useful. Sites formed by loop motion are promising for drug development, unlike those formed by side chain movement.
Area of Science:
- Protein science
- Drug discovery
- Biochemistry
Background:
- Cryptic sites represent untapped potential for expanding the repertoire of druggable proteins.
- Understanding the druggability of these sites is crucial before significant research investment.
- The precise mechanisms governing ligand binding in cryptic sites remain largely unexplored.
Purpose of the Study:
- To investigate the druggability of cryptic protein sites.
- To differentiate between types of cryptic sites based on their formation mechanism and potential for drug development.
- To provide a theoretical framework for understanding ligand binding kinetics in cryptic sites.
Main Methods:
- Analysis of protein-ligand interactions.
- Categorization of cryptic sites based on structural dynamics (side chain vs. loop/hinge motion).
- Application of classical enzyme inhibition theory and kinetic analysis.
Main Results:
- Cryptic sites formed by side chain motion typically exhibit insufficient binding potency for drug-sized molecules.
- Cryptic sites formed by loop or hinge motion demonstrate potential as valuable drug targets.
- Kinetic and theoretical analyses support the differential druggability based on site formation dynamics.
Conclusions:
- The mechanism of cryptic site formation is a critical determinant of its druggability.
- Loop or hinge-mediated cryptic sites are more promising for therapeutic intervention than side chain-mediated sites.
- Further research into loop/hinge-mediated cryptic sites could unlock new avenues in drug discovery.
More Related Videos
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
Related Concept Videos
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Drug Discovery: Overview
Ligand Binding and Linkage
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...